CV Sciences (CVSI) Change in Inventory (2013 - 2026)
CV Sciences (CVSI) reported Change in Inventory of -$174000.0 for Q1 2026, up 67.54% on a YoY basis from -$103857.5 in Q1 2025, and down 5900.0% sequentially from $3000.0 in Q4 2025.
CV Sciences (CVSI) Change in Inventory (2013 - 2026) Analysis & Trends
CV Sciences (CVSI) has 14 years of Change in Inventory data on file, last reported at -$174000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Inventory rose 67.54% year-over-year to -$174000.0; the trailing twelve-month figure through Mar 2026 stood at -$465000.0 (up 67.73% YoY), and the FY2025 full-year result was -$827000.0, down 2.99% from the prior year.
- Change in Inventory fell to -$174000.0 in Q1 2026, from $3000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $102000.0 in Q1 2024 to a low of -$880000.0 in Q2 2022.
- A 5-year average of -$288647.1 and a median of -$174000.0 in 2026 frame the typical range for Change in Inventory.
- Across the five-year window, Change in Inventory soared 375.68% in 2024 and tumbled 625.49% in 2025, its largest moves.
- Tracing CVSI's Change in Inventory over 5 years: stood at -$663000.0 in 2022, then surged by 68.63% to -$208000.0 in 2023, then surged by 45.19% to -$114000.0 in 2024, then soared by 102.63% to $3000.0 in 2025, then tumbled by 5900.0% to -$174000.0 in 2026.
- Business Quant data shows CVSI's Change in Inventory at -$174000.0 in Q1 2026, $3000.0 in Q4 2025, and -$132000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | -93.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 114.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | 119.24 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 40.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 123.00 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -4.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | CV Sciences | 3.74 Mn | 3.43 Mn | 1.56 Mn | -174,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -174,000.00 |
| Mar 31, 2026 | -174,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | -132,000.00 |
| Sep 30, 2025 | -132,000.00 |
| Jun 30, 2025 | -162,000.00 |
| Jun 30, 2025 | -162,000.00 |
| Mar 31, 2025 | -536,000.00 |
| Mar 31, 2025 | -536,000.00 |
| Dec 31, 2024 | -114,000.00 |
| Dec 31, 2024 | -114,000.00 |
| Sep 30, 2024 | -176,000.00 |
| Sep 30, 2024 | -176,000.00 |
| Jun 30, 2024 | -615,000.00 |
| Jun 30, 2024 | -615,000.00 |
| Mar 31, 2024 | 102,000.00 |
| Mar 31, 2024 | 102,000.00 |
| Dec 31, 2023 | -208,000.00 |
| Dec 31, 2023 | -208,000.00 |